Original language | English |
---|---|
Pages (from-to) | 1-30 |
Number of pages | 30 |
Journal | Esophagus |
Volume | 12 |
Issue number | 1 |
DOIs | |
Publication status | Published - 2015 Jan 1 |
Keywords
- Clinical guidelines
- Esophagus
- Neoplasm
ASJC Scopus subject areas
- Gastroenterology
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: Esophagus, Vol. 12, No. 1, 01.01.2015, p. 1-30.
Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - Guidelines for diagnosis and treatment of carcinoma of the Esophagus April 2012 edited by the Japan esophageal society
AU - Kuwano, Hiroyuki
AU - Nishimura, Yasumasa
AU - Oyama, Tsuneo
AU - Kato, Hiroyuki
AU - Kitagawa, Yuko
AU - Kusano, Motoyasu
AU - Shimada, Hideo
AU - Takiuchi, Hiroya
AU - Toh, Yasushi
AU - Doki, Yuichiro
AU - Naomoto, Yoshio
AU - Matsubara, Hisahiro
AU - Miyazaki, Tatsuya
AU - Muto, Manabu
AU - Yanagisawa, Akio
N1 - Funding Information: Funds to support the development of these guidelines were provided by the Japan Esophageal Society and the Ministry of Health, Labour and Welfare Scientific Research (Study on the appropriate development and publication of guidelines for the diagnosis and treatment while maintaining full disclosure: Hirata’s study group). Prof. Kitagawa has received grants from Taiho Pharmaceutical CO., LTD., Chugai Pharmaceutical CO., LTD., Kyowa Hakko Kirin CO., LTD., Merck Serono CO., LTD., Ono Pharmaceutical CO., LTD., Novartis Pharma CO., LTD., Yakult Honsha CO., LTD., Bristol-Myers Squibb Daiichi Sankyo CO., LTD., Shionogi CO., LTD., Terumo Corporation, Torii Pharmaceutical Co., Ltd., AstraZeneca CO., LTD. Other authors have no conflict of interest to declare with profit making or nonprofit organizations or providers of medical products and medical supplies. The Ethics Committee and Administrative Board of the Japan Esophageal Society required members of the Committee to Develop Guidelines for the Treatment of Carcinoma of the Esophagus and the Guideline Evaluation Committee to self-report any potential conflict of interest.
PY - 2015/1/1
Y1 - 2015/1/1
KW - Clinical guidelines
KW - Esophagus
KW - Neoplasm
UR - http://www.scopus.com/inward/record.url?scp=84929336574&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84929336574&partnerID=8YFLogxK
U2 - 10.1007/s10388-014-0465-1
DO - 10.1007/s10388-014-0465-1
M3 - Article
AN - SCOPUS:84929336574
SN - 1612-9059
VL - 12
SP - 1
EP - 30
JO - Esophagus
JF - Esophagus
IS - 1
ER -